Primary Job Title President Primary Organization 
ValueAct Capital
Gender Male
Mason Morfit is President of ValueAct Capital, a governance-oriented investment fund that invests in a concentrated portfolio of public companies and works actively with their executives and boards of directors on issues of strategy, capital structure, mergers and acquisitions, and talent management.
Morfit joined the Microsoft board of
directors in March 2014. He is a former director of Valeant Pharmaceuticals International, CR Bard, Inc., Immucor, Inc., Advanced Medical Optics, Solexa, Inc., and MSD Performance, Inc.
Prior to ValueAct Capital, Morfit worked in equity research for Credit Suisse First Boston’s health care group covering the managed care industry. He has a bachelor’s degree from Princeton University.
